Director Declaration - John O'Higgins

Summary by AI ^BETAClose X

Oxford Nanopore Technologies plc announced that John O'Higgins, a Non-Executive Director, has been nominated to join the Board of Technip Energies NV as Non-Executive Chair, pending approval at their Annual General Meeting on May 5, 2026. This development is a director declaration under Listing Rule 6.4.9 R(2).

Disclaimer*

Oxford Nanopore Technologies plc

27 February 2026

Oxford Nanopore Technologies plc

Director Declaration

Pursuant to Listing Rule 6.4.9 R(2), Oxford Nanopore Technologies plc (the "Company") confirms that John O'Higgins, Non-Executive Director of the Company, has been nominated for appointment to the Board of Technip Energies NV (PARIS: TE) as Non-Executive Chair, subject to approval at the Annual General Meeting of Technip Energies NV on 5 May 2026.

[ENDS]

For further information, please contact:

Oxford Nanopore Technologies plc

Investors: ir@nanoporetech.com

Media: media@nanoporetech.com

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END